MicrobiologybioRxivPreprint
APP and APLP2 Kunitz Domains Are Potent Endogenous Inhibitors of TMPRSS2 and Respiratory Virus Infection
Jan Lawrenz, Shreyans Chatterjee, Armando Rodríguez Alfonso…·Jan Münch
DOI 10.64898/2026.08.13.744607
Author
Jan Lawrenz
University Hospital UlmORCID 0000-0003-3767-7130Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2025-2026 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 37 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship3 papers
Recent·Most cited
- MicrobiologybioRxivPreprint
Tonic interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures
Rinu Sivarajan, Paul C. Kirchgatterer, Jan Lawrenz…·Konstantin M. J. Sparrer
The paper demonstrates that tonic interferons are critical for early antiviral defense in human lung organoid-derived air-liquid interface cultures against HRV16.
DOI 10.64898/2025.12.10.693424 - MicrobiologyAdvanced SciencePeer-reviewed
Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum 1 Efficacy Against Corona and Influenza Viruses
Jan Lawrenz, Lukas Wettstein, Armando Rodríguez…·Jan Münch
This paper identifies Trypstatin, a Kunitz-type protease inhibitor that inhibits TMPRSS2 and related proteases, showing broad-spectrum antiviral activity against SARS-CoV-2, influenza, and other respiratory viruses.